These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 8794603

  • 1. Angiotensin II antagonists: a new class of antihypertensive agent.
    Waeber B, Brunner HR.
    Br J Clin Pract; 1996; 50(5):265-8. PubMed ID: 8794603
    [Abstract] [Full Text] [Related]

  • 2. The advantages of angiotensin II antagonism.
    Burnier M, Waeber B, Brunner HR.
    J Hypertens Suppl; 1994 Jul; 12(2):S7-15. PubMed ID: 7965267
    [Abstract] [Full Text] [Related]

  • 3. Blood pressure effects of the angiotensin II receptor blocker, losartan.
    Weber MA, Byyny RL, Pratt JH, Faison EP, Snavely DB, Goldberg AI, Nelson EB.
    Arch Intern Med; 1995 Feb 27; 155(4):405-11. PubMed ID: 7848024
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin II receptors and angiotensin II receptor antagonists.
    Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, Smith RD.
    Pharmacol Rev; 1993 Jun 27; 45(2):205-51. PubMed ID: 8372104
    [No Abstract] [Full Text] [Related]

  • 5. The diversified pharmacology of angiotensin II-receptor blockade.
    Timmermans PB, Smith RD.
    Blood Press Suppl; 1996 Jun 27; 2():53-61. PubMed ID: 8913541
    [Abstract] [Full Text] [Related]

  • 6. Discovery of losartan, the first angiotensin II receptor antagonist.
    Timmermans PB, Duncia JV, Carini DJ, Chiu AT, Wong PC, Wexler RR, Smith RD.
    J Hum Hypertens; 1995 Nov 27; 9 Suppl 5():S3-18. PubMed ID: 8583479
    [Abstract] [Full Text] [Related]

  • 7. The future role of losartan.
    Hansson L.
    J Hum Hypertens; 1995 Nov 27; 9 Suppl 5():S55-8. PubMed ID: 8583483
    [Abstract] [Full Text] [Related]

  • 8. A new class of therapeutic agents: the angiotensin II receptor antagonists.
    Timmermans PB, Smith RD.
    Cardiologia; 1994 Dec 27; 39(12 Suppl 1):397-400. PubMed ID: 7634303
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin II receptor inhibition. A new therapeutic principle.
    Messerli FH, Weber MA, Brunner HR.
    Arch Intern Med; 1996 Sep 23; 156(17):1957-65. PubMed ID: 8823149
    [Abstract] [Full Text] [Related]

  • 10. Historical development of losartan (DuP 753) and angiotensin II receptor subtypes.
    Wong PC, Timmermans PB.
    Blood Press Suppl; 1996 Sep 23; 3():11-4. PubMed ID: 8973760
    [Abstract] [Full Text] [Related]

  • 11. Differential effects of oral losartan and enalapril on local venous and systemic pressor responses to angiotensin I and II in healthy men.
    Goldberg MR, de Mey C, Wroblewski JM, Li Q, Schroeter V, Belz GG.
    Clin Pharmacol Ther; 1996 Jan 23; 59(1):72-82. PubMed ID: 8549037
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin II receptor antagonists: the prototype losartan.
    Schaefer KL, Porter JA.
    Ann Pharmacother; 1996 Jun 23; 30(6):625-36. PubMed ID: 8792950
    [Abstract] [Full Text] [Related]

  • 13. Renal effects of angiotensin II receptor blockade and angiotensin-converting enzyme inhibition in healthy subjects.
    Burnier M, Brunner HR.
    Exp Nephrol; 1996 Jun 23; 4 Suppl 1():41-6. PubMed ID: 9001896
    [Abstract] [Full Text] [Related]

  • 14. ACE inhibitors, angiotensin II antagonists and cough. The Losartan Cough Study Group.
    Ramsay LE, Yeo WW.
    J Hum Hypertens; 1995 Nov 23; 9 Suppl 5():S51-4. PubMed ID: 8583482
    [Abstract] [Full Text] [Related]

  • 15. Angiotensin II blockade compared with other pharmacological methods of inhibiting the renin-angiotensin system.
    Brunner HR, Nussberger J, Waeber B.
    J Hypertens Suppl; 1993 Apr 23; 11(3):S53-8. PubMed ID: 8315521
    [Abstract] [Full Text] [Related]

  • 16. The angiotensin II receptor antagonist losartan: a new advance in the treatment of hypertension.
    Lacourcière Y.
    Can J Cardiol; 1995 Aug 23; 11 Suppl F():45F-48F. PubMed ID: 7664218
    [Abstract] [Full Text] [Related]

  • 17. How well have animal studies with losartan predicted responses in humans?
    Sweet CS, Nelson EB.
    J Hypertens Suppl; 1993 Apr 23; 11(3):S63-7. PubMed ID: 8315522
    [Abstract] [Full Text] [Related]

  • 18. Association between cough and angiotensin converting enzyme inhibitors versus angiotensin II antagonists: the design of a prospective, controlled study.
    Lacourcière Y, Lefebvre J, Nakhle G, Faison EP, Snavely DB, Nelson EB.
    J Hypertens Suppl; 1994 Jul 23; 12(2):S49-53. PubMed ID: 7965266
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of losartan.
    Goldberg A, Sweet C.
    Can J Cardiol; 1995 Aug 23; 11 Suppl F():27F-32F. PubMed ID: 7664215
    [Abstract] [Full Text] [Related]

  • 20. Clinical experience with angiotensin II receptor antagonists.
    Lee RJ, Brunner HR.
    J Hum Hypertens; 1993 Aug 23; 7 Suppl 2():S33-6. PubMed ID: 8230087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.